Prolonged hormonal therapy and external beam radiation independently increase the risk of Persistent Hypogonadism in men treated with prostate brachytherapy

To identify variables that predict persistent hypogonadism and castration in patients with prostate cancer (PCa) treated with brachytherapy (BT).

Source: Brachytherapy - January 16, 2020 Category: Cancer & Oncology Authors: Kyrollis Attalla, Daniel Sagalovich, Kathryn E. Marqueen, John P. Sfakianos, Ashutosh K. Tewari, Ketan K. Badani, Richard G. Stock, Nelson N. Stone Source Type: research